The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication
Authors
Keywords
-
Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 68, Issue 6, Pages 1079-1090
Publisher
Springer Nature
Online
2010-08-29
DOI
10.1007/s00018-010-0510-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Story of Human Cytomegalovirus and Cancer: Increasing Evidence and Open Questions
- (2015) Martin Michaelis et al. NEOPLASIA
- Monitoring of cytomegalovirus reactivation during induction and nontransplant consolidation of acute leukemia
- (2009) Monia Lunghi et al. AMERICAN JOURNAL OF HEMATOLOGY
- How we treat cytomegalovirus in hematopoietic cell transplant recipients
- (2009) M. Boeckh et al. BLOOD
- The Effect of Imatinib on Cytomegalovirus Reactivation in Hematopoietic Cell Transplantation
- (2009) Giovanna Travi et al. CLINICAL INFECTIOUS DISEASES
- Antiviral treatment of cytomegalovirus infection and resistant strains
- (2009) Andreas Schreiber et al. EXPERT OPINION ON PHARMACOTHERAPY
- New aspects of an anti-tumour drug: sorafenib efficiently inhibits HCV replication
- (2009) K. Himmelsbach et al. GUT
- Validation of an HPLC-UV method for sorafenib determination in human plasma and application to cancer patients in routine clinical practice
- (2009) B. Blanchet et al. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
- Activation of Telomerase by Human Cytomegalovirus
- (2009) K. Straat et al. JNCI-Journal of the National Cancer Institute
- BRAIN CANCER: A Viral Link to Glioblastoma?
- (2009) G. Miller SCIENCE
- Detection of human cytomegalovirus in different histological types of gliomas
- (2008) Michael E. Scheurer et al. ACTA NEUROPATHOLOGICA
- Protein kinase inhibitors of the quinazoline class exert anti-cytomegaloviral activity in vitro and in vivo
- (2008) Mark Schleiss et al. ANTIVIRAL RESEARCH
- Interruption of the Ras/MEK/ERK signaling cascade enhances Chk1 inhibitor-induced DNA damage in vitro and in vivo in human multiple myeloma cells
- (2008) Y. Dai et al. BLOOD
- Detection of cytomegalovirus reactivation in cancer patients receiving chemotherapy
- (2008) C.-P. Kuo et al. CLINICAL MICROBIOLOGY AND INFECTION
- Cytomegalovirus Reactivation in Critically Ill Immunocompetent Patients
- (2008) JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- HCMV microinfections in inflammatory diseases and cancer
- (2008) Cecilia Söderberg-Nauclér JOURNAL OF CLINICAL VIROLOGY
- Human cytomegalovirus: Latency and reactivation in the myeloid lineage
- (2008) John Sinclair JOURNAL OF CLINICAL VIROLOGY
- Platelet-derived growth factor-α receptor activation is required for human cytomegalovirus infection
- (2008) Liliana Soroceanu et al. NATURE
- A quantitative analysis of kinase inhibitor selectivity
- (2008) Mazen W Karaman et al. NATURE BIOTECHNOLOGY
- Is NF-κB a good target for cancer therapy? Hopes and pitfalls
- (2008) Véronique Baud et al. NATURE REVIEWS DRUG DISCOVERY
- Cytomegalovirus Immunity after Vaccination with Autologous Glioblastoma Lysate
- (2008) Robert M. Prins et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma
- (2007) Duane A. Mitchell et al. NEURO-ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation